A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer

Ann Oncol. 2015 Dec;26(12):2505. doi: 10.1093/annonc/mdv477. Epub 2015 Oct 21.

Authors

B H O'Neil¹, A J Scott², W W Ma³, S J Cohen⁴, L Leichman⁵, D L Aisner², A R Menter⁶, M A Tejani⁷, J K Cho⁸, J Granfortuna⁹, L Coveler¹⁰, O O Olowokure¹¹, J C Baranda¹², M Cusnir¹³, P Phillip¹⁴, J Boles¹⁵, R Nazemzadeh¹⁶, M Rarick¹⁷, D J Cohen¹⁸, J Radford¹⁹, L Fehrenbacher²⁰, R Bajaj²¹, V Bathini²², P Fanta²³, J Berlin²⁴, A J McRee²⁵, R Maguire²⁶, F Wilhelm²⁶, M Maniar²⁶, A Jimeno², C L Gomes²⁷, W A Messersmith²

Affiliations

¹ Simon Cancer Center, Indiana University School of Medicine, Indianapolis.
² University of Colorado, Denver, Aurora.
³ Roswell Park Cancer Institute, Buffalo.
⁴ Fox Chase Cancer Center, Philadelphia.
⁵ New York University, New York.
⁶ Kaiser Permanente, Lone Tree.
⁷ University of Rochester Medical Center, Rochester.
⁸ Oncare Hawaii, Honolulu.
⁹ Cone Health Cancer Center, Greensboro.
¹⁰ University of Washington, Seattle.
¹¹ University of Cincinnati Cancer Institute, Cincinnati.
¹² University of Kansas Medical Center, Westwood.
¹³ Mount Sinai Medical Center, Miami Beach.
¹⁴ Karmanos Cancer Institute, Detroit.
¹⁵ Rex Cancer Center UNC Healthcare, Raleigh.
¹⁶ Carolinas Health Care, Charlotte.
¹⁷ Kaiser Permanante Northwest, Portland.
¹⁸ NYU Clinical Cancer Center, New York.
¹⁹ Hendersonville Hematology and Oncology at Pardee, Hendersonville.
²⁰ Kaiser Permanante Medical Center, Vallejo.
²¹ McLeod Regional Medical Center, Florence.
²² University of Massachusetts Memorial, Worcester.
²³ UCSD Moores Cancer Center, La Jolla.
²⁴ Vanderbilt-Ingram Cancer Center, Nashville.
²⁵ UNC Lineberger Comprehensive Cancer Center, Chapel Hill.
²⁶ Onconova Therapeutics Inc., Newtown.
²⁷ Oncology Consortia of Criterium Inc., Saratoga Springs, USA.

No abstract available

Publication types

Published Erratum